News
Filter:
A Q&A with Hank Greeley: The First Gene-Edited Babies
Last month, He Jiankui, a Chinese researcher, announced the birth of the world’s first gene-edited babies, whose DNA had been edited to reduce the risk of HIV infection.
Encouraging Edge Science through NIH Funding Practices
Science moves forward when scientists take risks in their work and explore new, untested ideas, writes SHP's Jay Bhattacharya. For example, one of the hottest new ideas in cancer treatment involves using patients’ own immune cells to treat their cancer.
Proposed CMS rule about disclosing drug costs on TV ads could have public health & legal concerns
The Trump administration has proposed a new rule that would require direct-to-consumer TV advertisements for prescription drugs to disclose the price of their products.
The Centers for Medicare & Medicaid Services (CMS) said the disclosures would help consumers “make informed decisions that minimize not only their out-of-pocket costs, but also expenditures borne by Medicare and Medicaid, both of which are significant problems.”
Task Force: Patients at high risk of HIV should take daily preventive drug
A national panel of medical experts is recommending for the first time that clinicians offer daily preventive medication to patients who are at high risk of acquiring HIV/AIDS.
Global study predicts 20-percent rise in insulin use by 2030 — but half the world's diabetics who need it won’t get it
The amount of insulin needed to effectively treat type 2 diabetes will rise by more than 20 percent worldwide over the next 12 years, according to new research led by Stanford Health Policy’s Sanjay Basu.
Meet Suhani Jalota: PhD candidate in health policy who wants to help women help themselves
Suhani Jalota was only 20 years old when she established a foundation to help impoverished women in the slums of her native city, Mumbai. She was 23 when Forbes named her one of Asia’s 30-Under-30 Social Entrepreneurs as her foundation was taking off. Now, at the ripe old age of 24, she is embarking on her pursuit of a PhD in health policy on the econ track at Stanford Medicine’s Department of Health Research and Policy.
Beijing Workshop Explores Options for Interventions in Civil Wars
Shorenstein APARC’s U.S.-Asia Security Initiative (USASI), the American Academy of Arts and Sciences (AAAS), and the School for International Studies at Peking University recently co-hosted the security workshop “Civil Wars, Intrastate Violence, and International Responses.” Held in Beijing...
Understanding the link between preeclampsia and heart disease later in life
Stanford researchers are awarded a 4-year, $6 million NIH grant to study the links between preeclampsia and subsequent risk of atherosclerotic cardiovascular disease (ASCVD) as they grow older.
It's a win-win: Hospitals should apologize for mistakes
Research by Stanford Health Policy’s Michelle Mello looks at what happens when a group of hospitals started systematically acknowledging adverse outcomes in care by apologizing and proactively offering compensation where substandard care caused serious harm.
Q&A: Paul Wise and World Bank leader Jim Yong Kim
Stanford Health Policy's Paul Wise held a conversation with Dr. Jim Yong Kim, president of the World Bank Group about improving the health of the poorest communities around the world.
Subsidizing private insurance plans to provide Medicare and Medicaid benefits. Is it working?
U.S. social insurance programs traditionally have been paid out to beneficiaries directly by the federal government. But the last two decades have seen an accelerated effort to subsidize private health insurance plans to provide Medicare and Medicaid benefits.
How growing time constraints impact primary care physicians and patients
Some 450 million patient visits to primary care clinics occur in the United States each year. And as the shortage of doctors grows larger each year, primary care teams face increasing pressure both during patient encounters and outside the examining room.
Determining the cost-effectiveness of an innvovative cancer therapy for children
A cutting-edge treatment for blood cancer in children with promising short-term remission rates has nevertheless come under intense scrutiny due to its unprecedented cost. So Stanford researchers set out to determine whether the treatment is cost-effective.
An epidemic of poor-quality health care claims 5 million lives each year in lower-income countries
The number of deaths due to poor-quality health care is estimated to be five times higher than the annual global deaths from HIV/AIDS — and three times more than deaths from diabetes. That amounts to 5 million deaths per year in 137 low- and middle-income countries as a result of poor-quality care.
A billion guns worldwide lead to public health burden of homicides and suicides, particularly in United States
In the most comprehensive investigation of its kind, the findings published this week in the Journal of the American Medical Association (JAMA), show 64 percent of firearm-related deaths were homicides, 27 percent were suicides and 9 percent were unintentional deaths. “This constitutes a major public health problem for humanity,” said Stanford Health Policy’s David Studdert.
Are the opioid companies responsible for the epidemic?
In this Q&A, Stanford Law Professors Michelle Mello, an expert in health law and core faculty member at Stanford Health Policy, and Nora Freeman Engstrom, an expert in tort law and complex litigation, explain the scope of the opioid problem and discuss the latest cases and legal challenges.
Indirect child casualties of conflict far outnumber direct combatant deaths in Africa
More children die from the indirect impact of armed conflict in Africa than those killed in the crossfire and on the battlefields, according to a new study by Stanford researchers. The study is the first comprehensive analysis of the large and lingering effects of armed conflicts — civil wars, rebellions and interstate conflicts — on the health of noncombatants.
Women over 30 can now choose HPV test as only screening for cervical cancer
Federal health advisors say women can now consider three options when it's time for their cervical cancer screening tests. The influential group, the U.S. Preventive Services Task Force (USPSTF), has expanded its recommendations for this potentially life-saving exam.
Legal US immigrants may be scared to sign up for benefits
The Trump administration's immigration crackdown may be leading to an unintended consequence: a drop-off in benefits enrollment among legal Hispanic immigrants, according to new research by Stanford Health Policy's Marcella Alsan.
A better way to measure progress toward the UN Sustainable Development Goals
A new calculation that combines health and economic well-being at the population level could help to better measure progress toward the U.N. Sustainable Development Goals and illuminate major disparities in health and living standards across countries, and between men and women, according to a new study by Stanford and Harvard researchers.
More racial diversity among physicians would lead to better health among black men, research shows
African-American doctors could help reduce cardiovascular mortality among black men by 19 percent — if there was more racial diversity among physicians, according to a new study led by Stanford Health Policy’s Marcella Alsan.
Rosenkranz Prize winner hopes to develop malaria vaccine targeting pregnant women
Pregnant women and their unborn children are more susceptible to the adverse consequences of malaria. This year's Rosenkranz Prize winner, Prasanna Jagannathan, is investigating new strategies to lay the foundation for a vaccine to prevent malaria in pregnancy.
More C02 in the air could lead to more human disease
The rising level of carbon dioxide in the atmosphere means that crops are becoming less nutritious, and that change could lead to higher rates of malnutrition that predispose people to various diseases.
Hospitals should consider underused resource to cut costs and promote value-based care
There is a wealth of data that could help hospitals cut costs while still providing high-quality service for patients, if physicians were willing to join forces with administrators to truly understand how much their services cost, according to a new article by Stanford researchers.
Most clinical trial participants find benefits outweigh risks in sharing personal data
Most participants in clinical trials believe the benefits of broadly sharing person-level data outweigh the risks, according to new research by Stanford Health Policy's Michelle Mello.
Pages
Members of the media should contact Stanford Health Policy Communications Manager Beth Duff-Brown
650-736-6064